Canagliflozin alleviates high glucose-induced peritoneal fibrosis via HIF-1α inhibition

• Main Authors: Jian Wang (Author), Xin Lv (Author), A- (Author), Sha-Sha Tian (Author), Jun-Mei Wang (Author), Hong-Yan Liu (Author), Xiao-Guang Fan (Author), Sai-Jun Zhou (Author), Pei Yu (Author)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2023-05-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

The cardioprotective effects of sodium-glucose cotransporter type 2 (SGLT2) inhibitors have been demonstrated in many studies. However, their benefits for end-stage kidney disease patients, particularly those on peritoneal dialysis, remain unclear. SGLT2 inhibition has shown peritoneal protective ef...